Modelling the healthcare costs of skin cancer in South Africa

BMC Health Services Research

Volumn 16, Issue 1, 2016, Pages

  Gordon, Louisa G ^a,b   Elliott, Thomas M ^a,b   Wright, Caradee Y ^c   Deghaye, Nicola ^d   Visser, Willie ^e  

^a GRIFFITH UNIVERSITY   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c UNIVERSITY OF PRETORIA   (South Africa)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Basal cell carcinoma; Cost of illness; Melanoma; Skin cancer; Squamous cell carcinoma

Indexed keywords

ADULT; ADVERSE EFFECTS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; PUBLIC HEALTH; SKIN NEOPLASMS; SOUTH AFRICA; STATISTICS AND NUMERICAL DATA; ULTRAVIOLET RADIATION;

ADULT; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HEALTH CARE COSTS; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; PUBLIC HEALTH; SKIN NEOPLASMS; SOUTH AFRICA; ULTRAVIOLET RAYS;

EID: 84963764465     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/s12913-016-1364-z     Document Type: Article

References (30)

1. Norval M, Kellett P, Wright CY. The incidence and body site of skin cancers in the population groups of South Africa. Photodermatol Photoimmunol Photomed. 2014;30(5):262-5.
2. Melanoma Fact Sheet [ http://www.melanoma.co.za/D-doccnr-MFS.asp ]. Accessed 24 Feb 2015.
3. Wright CY, Norval M, Summers B, Davids LM, Coetzee G, Oriowo M. Solar ultraviolet radiation exposure and human health in South Africa: finding a balance. S Afr Med J. 2012;102(8):665-6.
4. Africa SS. Mid-year population estimates. In: Africa SS; 2014.
5. Stein L, Urban MI, O'Connell D, Yu XQ, Beral V, Newton R, Ruff P, Donde B, Hale M, Patel M, et al. The spectrum of human immunodeficiency virus-associated cancers in a South African black population: results from a case-control study, 1995-2004. Int J Cancer. 2008;122(10):2260-5.
6. Pillay Y, Barron P. Progress towards the millennium development goals in SA. S Afr Med J. 2014;104(3 Suppl 1):223.
7. Jessop S, Stubbings H, Sayed R, Duncan-Smith J, Schneider JW, Jordaan HF. Regional clinical registry data show increased incidence of cutaneous melanoma in Cape Town. S Afr Med J. 2008;98(3):197-9.
8. Singh JMU E, Nattey C, Babb C, Sengayi M, Kellet P. South African National Cancer Registry: Effect of withheld data from private health systems on cancer incidence estimates. S Afr Med J. 2015;105(2):107-10.
9. Guy Jr GP, Machlin SR, Ekwueme DU, Yabroff KR. Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011. Am J Prev Med. 2015;48(2):183-7.
10. Vallejo-Torres L, Morris S, Kinge JM, Poirier V, Verne J. Measuring current and future cost of skin cancer in England. J Public Health (Oxf). 2014;36(1):140-8.
11. Chapko MK, Liu CF, Perkins M, Li YF, Fortney JC, Maciejewski ML. Equivalence of two healthcare costing methods: bottom-up and top-down. Health Econ. 2009;18(10):1188-201.
12. Fong ZV, Tanabe KK. Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review. Br J Dermatol. 2014;170(1):20-30.
13. Team U. Uniform Patient Fee Schedule. In: Africa NDoHRoS. Pretoria; 2014.
14. Registry SAMP. Master Procurement Catalogue November 2014. In: HEALTH NDO. Pretoria; 2014.
15. Girgis A, Clarke P, Burton RC, Sanson-Fisher RW. Screening for melanoma by primary health care physicians: a cost-effectiveness analysis. J Med Screen. 1996;3(1):47-53.
16. Guy GP, Ekwueme DU. Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature. Pharmacoeconomics. 2011;29(10):863-74.
17. Garattini L, Cainelli T, Tribbia G, Scopelliti D. Economic evaluation of an educational campaign for early diagnosis of cutaneous melanoma. Pharmacoeconomics. 1996;9(2):146-55.
18. Gordon LG, Scuffham PA, van der Pols JC, McBride P, Williams GM, Green AC. Regular sunscreen use is a cost-effective approach to skin cancer prevention in subtropical settings. J Invest Dermatol. 2009;129(12):2766-71.
19. Hirst N, Gordon L, Gies P, Green AC. Estimation of avoidable skin cancers and cost-savings to government associated with regulation of the solarium industry in Australia. Health Policy. 2009;89(3):303-11.
20. Hirst NG, Gordon LG, Scuffham PA, Green AC. Lifetime cost-effectiveness of skin cancer prevention through promotion of daily sunscreen use. Value Health. 2012;15(2):261-8.
21. Kyle JW, Hammitt JK, Lim HW, Geller AC, Hall-Jordan LH, Maibach EW, De Fabo EC, Wagner MC. Economic evaluation of the US Environmental Protection Agency's SunWise program: sun protection education for young children. Pediatrics. 2008;121(5):e1074-1084.
22. Shih ST, Carter R, Sinclair C, Mihalopoulos C, Vos T. Economic evaluation of skin cancer prevention in Australia. Prev Med. 2009;49(5):449-53.
23. Health NDo. National Health Insurance Green Paper. In: Health NDo. Pretoria; 2011.
24. McLaren ZM, Ardington C, Leibbrandt M. Distance decay and persistent health care disparities in South Africa. BMC Health Serv Res. 2014;14:541.
25. Harris B, Goudge J, Ataguba JE, McIntyre D, Nxumalo N, Jikwana S, Chersich M. Inequities in access to health care in South Africa. J Public Health Policy. 2011;32 Suppl 1:S102-123.
26. Hudson DA, Krige JE. Melanoma in black South Africans. J Am Coll Surg. 1995;180(1):65-71.
27. Lodder JV, Simson W, Becker PJ. Malignant melanoma of the skin in black South Africans: a 15-year experience. S Afr J Surg. 2010;48(3):76-9.
28. Krige JE, Isaacs S, Hudson DA, King HS, Strover RM, Johnson CA. Delay in the diagnosis of cutaneous malignant melanoma. A prospective study in 250 patients. Cancer. 1991;68(9):2064-8.
29. Gordon LG, Rowell D. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review. Eur J Cancer Prev. 2015;24(2):141-9.
30. Briggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force - 6. Value Health. 2012;15(6):835-42.